Among the companies with shares expected to trade actively in Friday's session are Avon Products Inc. (AVP), Ambarella Inc. (AMBA), and Norfolk Southern Corp. (NSC).

Avon Products on Friday responded to activist investor Barington Capital Group LP's public campaign launched Thursday to turn the beauty-products seller around, saying it welcomes shareholder feedback. Shares of Avon rose 7.8% to $4.30 in premarket trading.

Ambarella, a key chip supplier to GoPro Inc. (GPRO), on Thursday gave a soft revenue outlook for its current quarter, citing weakness in the wearable camera market. Shares fell 9% to $52.66 premarket.

Norfolk Southern has rejected Canadian Pacific Railway Ltd.'s (CP, CP.T)unsolicited acquisition offer, valued at over $28 billion, saying the tie-up undervalues the company and is unlikely to be cleared by regulators. Shares fell 3.9% to $89.50 in early trading.

Zumiez Inc. (ZUMZ) projects it will close the year with results well below Wall Street projections, as it hasn't been able to break a sales slowdown in the U.S. Shares of the apparel retailer tumbled 15% to $11.85 premarket.

Teen retailer Five Below Inc. (FIVE) on Thursday raised the low end of its sales projection for the year, anticipating that strong sales momentum from the third quarter will carry into the holiday season. Shares rose 9.4% to $30.54 premarket.

Barnes & Noble Inc. (BKS) swung to a loss and reported a decline in sales in the first full quarter since completing the separation of its college business.

Ulta Salon, Cosmetics & Fragrance Inc. (ULTA) posted better-than-expected profit and revenue in its latest quarter, pushing it to boost its guidance for the year.

Drug makers Amgen Inc. (AMGN) and Merck & Co. (MRK) said Friday that they will team up to conduct two clinical trials evaluating a burgeoning class of drugs that use the body's immune system to fight cancer.

Contact-lens company Cooper Cos. (COO) on Thursday gave a disappointing outlook for its newly started fiscal year and reported results for its latest quarter that missed the company's expectations. Shares of Cooper fell 12% to $125.00 premarket.

Gap Inc. (GPS) said sales at its established stores fell 8% in November, worse than analysts expected, with declines at all three of its major brands. Shares fell 4.3% to $25.00 premarket.

NU Skin Enterprises Inc. (NUS) on Friday said it expects revenue growth between 5% and 7% in 2016 on strong sales of its new ageLOC line.

Mylan N.V. (MYL) said Friday that it has received a subpoena from the U.S. Justice Department's antitrust division related to the marketing and pricing of its generic antibiotic Doxycycline.

Galena Biopharma Inc. (GALE) said Friday it has agreed to settle federal lawsuits that accused the company of running a "pump-and-dump," scheme by falsely inflating its stock prices to then profit with a selloff.

Eli Lilly & Co. (LLY) said Friday it was halting development of diabetes treatment basal insulin peglispro because of development costs after the drug was found to have increased liver fat during trials.

Write to Jenny Roth at jenny.roth@wsj.com and Maria Armental at maria.armental@wsj.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

(END) Dow Jones Newswires

December 04, 2015 09:30 ET (14:30 GMT)

Copyright (c) 2015 Dow Jones & Company, Inc.
Mylan NV (NASDAQ:MYL)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Mylan NV Charts.
Mylan NV (NASDAQ:MYL)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Mylan NV Charts.